GB0821839D0 - The use of metformin and compounds containing metformin in the treatment of diseases or conditions in patients with raised serum amyloid A - Google Patents
The use of metformin and compounds containing metformin in the treatment of diseases or conditions in patients with raised serum amyloid AInfo
- Publication number
- GB0821839D0 GB0821839D0 GBGB0821839.8A GB0821839A GB0821839D0 GB 0821839 D0 GB0821839 D0 GB 0821839D0 GB 0821839 A GB0821839 A GB 0821839A GB 0821839 D0 GB0821839 D0 GB 0821839D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- metformin
- patients
- diseases
- treatment
- conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title 2
- 229960003105 metformin Drugs 0.000 title 2
- 102000054727 Serum Amyloid A Human genes 0.000 title 1
- 108700028909 Serum Amyloid A Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0821839A GB2465796A (en) | 2008-12-01 | 2008-12-01 | Metformin for the therapeutic use of conditions with raised serum amyloid A levels |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0821839A GB2465796A (en) | 2008-12-01 | 2008-12-01 | Metformin for the therapeutic use of conditions with raised serum amyloid A levels |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0821839D0 true GB0821839D0 (en) | 2009-01-07 |
GB2465796A GB2465796A (en) | 2010-06-02 |
Family
ID=40262405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0821839A Withdrawn GB2465796A (en) | 2008-12-01 | 2008-12-01 | Metformin for the therapeutic use of conditions with raised serum amyloid A levels |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2465796A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113186275A (en) * | 2021-06-16 | 2021-07-30 | 上海交通大学医学院附属仁济医院 | Application of serum amyloid A1 in preparation of biomarker for diagnosing polycystic ovarian syndrome |
CN113712962A (en) * | 2021-09-30 | 2021-11-30 | 深圳市第三人民医院(深圳市肝病研究所) | Application of troglitazone in anti-mycobacterium tuberculosis drugs |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012095379A1 (en) * | 2011-01-11 | 2012-07-19 | Universität Basel | Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression |
SG11201501719UA (en) * | 2012-09-07 | 2015-04-29 | Agency Science Tech & Res | Methods to inhibit intracellular growth of bacteria and to treat bacteria-mediated diseases |
WO2016192098A1 (en) * | 2015-06-05 | 2016-12-08 | 台中荣民总医院 | Pharmaceutical composition containing acarbose and use thereof in regulating immunization |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002543118A (en) * | 1999-04-29 | 2002-12-17 | シティ・オブ・ホープ | Pentoxifylline, pioglitazone and metformin are inhibitors of the formation of advanced glycation end products (AGE) |
WO2005046675A2 (en) * | 2003-11-07 | 2005-05-26 | Jordan Holtzman | Methods for enhancing glutathione peroxidase activity |
AU2005299808B2 (en) * | 2004-10-25 | 2009-08-20 | Novartis Ag | Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin |
JOP20180109A1 (en) * | 2005-09-29 | 2019-01-30 | Novartis Ag | New Formulation |
WO2008141074A1 (en) * | 2007-05-10 | 2008-11-20 | Salk Institute For Biological Studies | Identification of compounds that protect against amyloid diseases |
-
2008
- 2008-12-01 GB GB0821839A patent/GB2465796A/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113186275A (en) * | 2021-06-16 | 2021-07-30 | 上海交通大学医学院附属仁济医院 | Application of serum amyloid A1 in preparation of biomarker for diagnosing polycystic ovarian syndrome |
CN113712962A (en) * | 2021-09-30 | 2021-11-30 | 深圳市第三人民医院(深圳市肝病研究所) | Application of troglitazone in anti-mycobacterium tuberculosis drugs |
Also Published As
Publication number | Publication date |
---|---|
GB2465796A (en) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL210856A0 (en) | Combination therapy for the treatment of diabetes and related conditions | |
IL209887A0 (en) | Treatment for diabetes in patients inappropriate for metformin therapy | |
IL190733A0 (en) | Methods and compositions for use in treatment of patients with autoantibody positive diseases | |
EP1985302A4 (en) | Medicament for treatment of tumor and the use thereof | |
HK1158705A1 (en) | Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions | |
IL219945A (en) | Double-acylated glp-1 derivatives and their use in the manufacture of a medicament for treating diabetes | |
PL1912650T3 (en) | Use of flibanserin in the treatment of obesity | |
PT2614832T (en) | Diagnosis and treatment of preeclampsia | |
EP2182978A4 (en) | Tissue kallikrein for the treatment of diseases associated with amyloid protein | |
PL2148667T3 (en) | Use of cyclohexanehexol derivatives in the treatment of ocular diseases | |
ZA200806808B (en) | Treatment of stressed patients | |
IL212672A (en) | Cycloundecadepsipeptide compounds and use of said compounds in the manufacture of medicaments | |
HK1168283A1 (en) | Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto sorcs1 | |
GB0821839D0 (en) | The use of metformin and compounds containing metformin in the treatment of diseases or conditions in patients with raised serum amyloid A | |
IL177609A (en) | Use of gabaculine or its analog in the manufacture of a medicament for treating hepatocellular carcinoma | |
IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
GB2458868B (en) | Fluphenazine based combination for use in the treatment of protein aggregation diseases | |
IL211267A (en) | Oxadiazole derivatives and medicaments and use thereof for the treatment of diabetes | |
ZA200807874B (en) | Preventative treatment and remission of allergic diseases | |
HRP20151393T8 (en) | USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES | |
ZA200904755B (en) | Use of epothilones in the treatment of osteoporosis and related diseases | |
GB201020621D0 (en) | Pin for hygienic and/or medical use in the anal region | |
PL2160213T3 (en) | Kit for the extracorporeal treatment of a biological fluid of a patient, and unit provided with said kit | |
EP2231163A4 (en) | Compounds and therapeutic use thereof | |
PT2182954T (en) | Use of nor-bile acids in the treatment of arteriosclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |